CNO
CNO Financial Group, Inc.
- Financial
- US companies in Insurance - Life (11)
- NYSE · USD
- Mkt cap $5.0bn
$54.44
as of 27 Oct 2026, 5% below its 52-week high
Screens as well placed to keep growing its dividend, with low cut-risk signals. Its valuation looks somewhat extended against its own history.
These scores are a resilience check on the dividend, not a recommendation to buy or sell. They are not financial advice.
- Trailing yield
- 1.29%Last 12 months of regular payments at today's price
- Forward yield
- 1.37%Each payment expected in the next 12 months, not the latest one doubled
- Cash cover
- 10.5×Free cash flow over dividends paid
- Earnings cover
- 4.2×Insurers and banks set dividends from capital generation, so their accounting earnings can sit well below the payout.
- 5y dividend growth
- +7.3% a yearNo cut since FY2014
- Next ex-dividend date
- Estimated10 Dec 2026Quarterly dividend of about $0.18
Compared with US companies in Insurance - Life (11)
- Trailing yield is lower than 9 of the 10 other US companies in Insurance - Life.
- 5y dividend growth (as paid) is lower than 5 of the 8 other US companies in Insurance - Life with a 5y growth figure.
Quality
84
HighCapacity to keep growing the dividend
Risk
0
LowSignals of dividend-cut pressure
Trim
61
ModerateHow extended the valuation looks
Why Trim is 61
CNO against US companies in Insurance - Life (11)
Valuation against its own history
As of the last reported period (30 Jun 2026). P80 means the figure is higher than 80% of CNO’s past readings.
- P/E17.0×P88, poor for this measure
- Yield1.35%P1, poor for this measure
- FCF payout9.5%P14, good for this measure
- DGR 5y+7.1%P0, poor for this measure
- ROIC1.2%P48, neutral for this measure
Net debt / EBITDA is left out: for banks and insurers, debt is part of the business, so the ratio says little.
Open valuation historyForecast your income with the CNO dividend calculator
Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.